Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

SELL
$50.28 - $64.61 $40,022 - $51,429
-796 Reduced 8.45%
8,624 $500,000
Q2 2023

Jul 10, 2023

BUY
$37.29 - $53.83 $351,271 - $507,078
9,420 New
9,420 $507,000
Q4 2019

Jan 15, 2020

SELL
$55.65 - $79.83 $189,599 - $271,980
-3,407 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$64.7 - $85.39 $102,484 - $135,257
-1,584 Reduced 31.74%
3,407 $248,000
Q2 2019

Jul 22, 2019

BUY
$67.77 - $82.2 $107,754 - $130,698
1,590 Added 46.75%
4,991 $410,000
Q1 2019

May 14, 2019

BUY
$45.83 - $70.54 $155,867 - $239,906
3,401 New
3,401 $240,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.